Literature DB >> 13051758

Hypercalcemia, a complication of hormone therapy of advanced breast cancer.

B J KENNEDY, D M TIBBETTS, I T NATHANSON, J C AUB.   

Abstract

Entities:  

Keywords:  BLOOD; BREAST/neoplasms; CALCIUM/in blood; SEX HORMONES/therapeutic use

Mesh：

Substances：

Year:  1953        PMID： 13051758

Source DB:  PubMed          Journal:  Cancer Res        ISSN： 0008-5472            Impact factor:   12.701


× No keyword cloud information.
  7 in total

1.  The chemical control of cancer.

Authors:  J F HOLLAND
Journal:  Public Health Rep       Date:  1954-12       Impact factor: 2.792

Review 2.  The pathophysiology and clinical aspects of hypercalcemic disorders.

Authors:  D B Lee; E T Zawada; C R Kleeman
Journal:  West J Med       Date:  1978-10

Review 3.  Current status of the management of patients with endocrine-sensitive tumors. I. Introduction and carcinoma of the breast.

Authors:  L G Crowley
Journal:  Calif Med       Date:  1969-01

4.  [Phosphate treatment in hypercalcemia].

Authors:  H J Kistler; W Neubauer
Journal:  Klin Wochenschr       Date:  1970-06-15

5.  Phosphate treatment of hypercalcaemia due to carcinoma.

Authors:  N Thalassinos; G F Joplin
Journal:  Br Med J       Date:  1968-10-05

6.  Phase I clinical and pharmacokinetics study of high-dose toremifene in postmenopausal patients with advanced breast cancer.

Authors:  J Bishop; R Murray; L Webster; P Pitt; K Stokes; A Fennessy; I Olver; G Leber
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

7.  Estrogens and antiestrogens stimulate release of bone resorbing activity by cultured human breast cancer cells.

Authors:  A Valentin-Opran; G Eilon; S Saez; G R Mundy
Journal:  J Clin Invest       Date:  1985-02       Impact factor: 14.808
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.